Fairfield, Bush & Co’s iShares Biotechnology ETF IBB Stock Holding History

Fairfield, Bush & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,353	Closed	-$228K	–	122
2025 Q4	$228K	Buy	+1,353	New	+$220K	0.12%	107
2024 Q1	–	Sell	-793	Closed	-$108K	–	263
2023 Q4	$108K	Buy	+793	New	+$96.8K	0.06%	144
2023 Q3	–	Sell	-118	Closed	-$15K	–	277
2023 Q2	$15K	Buy	+118	New	+$15.3K	﹤0.01%	288
2022 Q3	–	Sell	-159	Closed	-$19K	–	260
2022 Q2	$19K	Buy	+159	New	+$18.9K	0.01%	261

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fairfield, Bush & Co's IBB Position: Q1 2026 in Review

Fairfield, Bush & Co sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 1,353 shares — an estimated $228K sold.

Fairfield, Bush & Co first reported a position in IBB in Q2 2022 and held it in 4 quarters. The position peaked at $228K in Q4 2025. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Fairfield, Bush & Co reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Fairfield, Bush & Co sold 1,353 iShares Biotechnology ETF shares in Q1 2026, an estimated $228K.
Fairfield, Bush & Co first reported a position in iShares Biotechnology ETF in Q2 2022 and held it in 4 quarters.
Fairfield, Bush & Co's iShares Biotechnology ETF position peaked at $228K in Q4 2025.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.